MURINE MONOCLONAL-ANTIBODY RECOGNIZING A 90-KDA CELL-SURFACE DETERMINANT SELECTIVELY LOST BY MULTI-DRUG-RESISTANT VARIANTS OF CEM CELLS

被引:27
作者
CIANFRIGLIA, M
CENCIARELLI, C
TOMBESI, M
BARCA, S
MARIANI, M
MORRONE, S
SANTONI, A
SAMOGGIA, P
ALESSIO, M
MALAVASI, F
机构
[1] SORIN BIOMED SPA,ONCOL BIOCHIM,SALUGGIA,ITALY
[2] UNIV ROME LA SAPIENZA,FAC MED,IST PATOL GEN,CATTEDRA 3,I-00185 ROME,ITALY
[3] IST SUPER SANITA,EMATOL LAB,I-00161 ROME,ITALY
[4] UNIV TURIN,DIPARTIMENTO GENET BIOL & CHIM MED,BIOL CELLULARE LAB,I-10124 TURIN,ITALY
关键词
D O I
10.1002/ijc.2910450118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We describe a murine IgG, monoclonal antibody (MAb56), specific for a cell‐surface protein structure (MC56 determinant) expressed by the human CEM cell line. A large band of approximately 90 kDa was identified as the main specific component of the MC56 determinant. Such a 90‐kDa protein is significantly associated with the drug‐sensitive phenotype, its expression being progressively reduced quantitatively in multi‐drug‐resistant (MDR) variants of CEM cells, according to the extent of drug resistance. In addition, the MC56 determinant is expressed de novo in drug‐sensitive revertant cell lines derived from MDR cells and unreactive with the MAb56. The MAb56 shows a high affinity towards the immunizing drug‐sensitive CEM cell line (Ka =1.86 × 109 L/mole) while not binding to MDR cell variants. The expression of the MC56 molecule on a variety of human cells and tissues makes such a cellular determinant a candidate as a marker for studying the MDR phenomenon both in vivo and in vitro. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:95 / 103
页数:9
相关论文
共 45 条
[31]  
LING V, 1977, MEMBRANE TOXICITY, P247
[32]   MICROPLATE SELECTION TECHNIQUE (MPST) - A NEW METHOD FOR SELECTING MOUSE TRANSFECTANTS EXPRESSING HUMAN-GENE PRODUCTS [J].
PERUZZI, L ;
MELIOLI, G ;
DEMONTE, LB ;
ALESSIO, M ;
ZACCOLO, M ;
ROGGERO, S ;
BELLONE, G ;
FUNARO, A ;
MALAVASI, F .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 123 (01) :113-121
[33]   GANGLIOSIDE COMPOSITION OF MALIGNANT AND ACTINOMYCIN D-RESISTANT NONMALIGNANT CHINESE-HAMSTER CELLS [J].
PETERSON, RHF ;
BEUTLER, WJ ;
BIEDLER, JL .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (05) :579-582
[34]   PLASMA-MEMBRANE PROTEINS AND GLYCOPROTEINS FROM CHINESE-HAMSTER CELLS SENSITIVE AND RESISTANT TO ACTINOMYCIN-D [J].
PETERSON, RHF ;
BIEDLER, JL .
JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1978, 9 (03) :289-298
[35]  
PETERSON RHF, 1983, CANCER RES, V43, P222
[36]   SOMATIC-CELL GENETICS AND ITS APPLICATION TO MEDICINE [J].
PUCK, TT ;
KAO, FT .
ANNUAL REVIEW OF GENETICS, 1982, 16 :225-271
[37]   MULTIPLY DRUG-RESISTANT HUMAN KB CARCINOMA-CELLS HAVE DECREASED AMOUNTS OF A 75-KDA AND A 72-KDA GLYCOPROTEIN [J].
RICHERT, N ;
AKIYAMA, S ;
SHEN, DW ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) :2330-2333
[38]   GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF MULTIDRUG RESISTANCE [J].
RIORDAN, JR ;
LING, V .
PHARMACOLOGY & THERAPEUTICS, 1985, 28 (01) :51-75
[39]  
RIORDAN JR, 1979, J BIOL CHEM, V254, P2701
[40]  
SHEN DW, 1986, J BIOL CHEM, V261, P7762